Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Sarah, Blach"'
Autor:
Mário Peribañez Gonzalez, Loraine Melissa Dal-Ri, Homie Razavi, Ivane Gramkrelidze, Sarah Blach, Carlos Alberto de Albuquerque Almeida Junior, Karen Cristine Tonini, Ana Paula Maciel Gurski, Aline Almeida da Silva, Ana Cristina Garcia Ferreira, Paulo Roberto Abrão Ferreira, Draurio Barreira
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 27, Iss , Pp 103070- (2023)
Introdução/Objetivo: Em 2016, o Brasil se comprometeu a eliminar as hepatites virais como problema de saúde pública até 2030 ao aderir à Estratégia Global do Setor de Saúde. Para estabelecer metas nacionais, o Ministério da Saúde, em parcer
Externí odkaz:
https://doaj.org/article/8b6873561a144211a3c979c09182c97d
Autor:
Sarah Blach, Kimberly A. Brown, Robert S. Brown, Pierre M. Gholam, Norah A. Terrault, Chris Estes, Homie A. Razavi
Publikováno v:
Journal of Infection and Public Health, Vol 16, Iss 1, Pp 64-70 (2023)
Background: As of 2019, the United States (US) was not on track to achieve targets for elimination, due to increasing incidence and treatment barriers. In 2020, the COVID-19 pandemic disrupted HCV services globally and in the US. As healthcare servic
Externí odkaz:
https://doaj.org/article/3abc5c2eb6014217b655a09cfa31abfe
Autor:
Francesco Negro, Beat Müllhaupt, David Semela, Sarah Blach, Philip Bruggmann, Andrea De Gottardi, Jean-Francois Dufour, Montserrat Fraga, Antonio Galante, Homie Razavi, Joana Vieira Barbosa, Devin Razavi-Shearer
Publikováno v:
Swiss Medical Weekly, Vol 153, Iss 6 (2023)
BACKGROUND AND AIMS: Chronic hepatitis B infection (defined as sustained detection of hepatitis B virus [HBV] surface antigen [HBsAg] protein in serum) is a leading cause of cirrhosis, hepatocellular carcinoma and liver-related deaths. A situation an
Externí odkaz:
https://doaj.org/article/7cacb93e21b04215885d23202568b527
Autor:
Dana Busschots, Erwin Ho, Sarah Blach, Frederik Nevens, Homie Razavi, Brieuc Van Damme, Thomas Vanwolleghem, Geert Robaeys
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Chronic infection with the hepatitis C virus (HCV) remains a worldwide health problem. As a result, the World Health Organization (WHO) has set elimination targets by 2030. This study aims to examine the position of Belgium in mee
Externí odkaz:
https://doaj.org/article/dd9fd1efdfe349c5b9c33b92f7a5c0c7
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0272518 (2022)
Aims of the studySince 2014, the Swiss Hepatitis Strategy (SHS) has targeted the elimination of Hepatitis C Virus (HCV) in Switzerland. The epidemiology of HCV is diverse across Swiss cantons, therefore cantonal-level screening and treatment strategi
Externí odkaz:
https://doaj.org/article/d33ff46f6e4740bb9ce5522b34877699
Autor:
Ellen Mooneyhan, Huma Qureshi, Hassan Mahmood, Muhammad Tariq, Nabeel Ahmed Maqbool, Masood Anwar, Mujahid Aslam, Farooq Azam, Sarah Blach, Aamir Ghafoor Khan, Saeed Hamid, Tanweer Hussain, Mohammad Khalil Akhter, Ambreen Khan, Uzma Khan, Saira Khowaja, Khalid Mahmood, Samra Mazhar, Ahmad Nawaz, Ayub Rose, Gul Sabeen Azam Ghorezai, Sabeen Shah, Syeda Zahida Sarwar, Homie Razavi
Publikováno v:
Journal of Viral Hepatitis. 30:345-354
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 1112 (2019)
BACKGROUND AND AIMS A previous analysis of hepatitis C virus (HCV)-related healthcare costs in Switzerland found that the annual healthcare costs of untreated HCV infection (excluding antiviral treatment) could increase by more than 25 million Swiss
Externí odkaz:
https://doaj.org/article/de1fd2fc269240ddbbc471a0074b60bf
Autor:
Urs Rusch, Sarah Robbins, Homie Razavi, Pietro Vernazza, Sarah Blach, Philip Bruggmann, Beat Müllhaupt, Francesco Negro, David Semela
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 0304 (2019)
BACKGROUND AND AIMS Direct-acting antiviral agents have revolutionised hepatitis C treatment. In 2014, the Swiss Hepatitis Strategy was developed to eliminate hepatitis C virus (HCV) infection and the associated liver-related morbidity and mortality
Externí odkaz:
https://doaj.org/article/ef0d19be32bb4a2692fe426ee0baad00
Autor:
Sameera Ezzat, Ivane Gamkrelidze, Alaa Osman, Asmaa Gomaa, Ayat Roushdy, Gamal Esmat, Homie Razavi, Sarah Blach, Wael Abdel‐Razek, Wafaa El‐Akel, Imam Waked
Publikováno v:
Liver International.
Autor:
Homie A. Razavi, Maria Buti, Norah A. Terrault, Stefan Zeuzem, Cihan Yurdaydin, Junko Tanaka, Alessio Aghemo, Ulus S. Akarca, Nasser M. Al Masri, Abduljaleel M. Alalwan, Soo Aleman, Abdullah S. Alghamdi, Saad Alghamdi, Waleed K. Al-Hamoudi, Abdulrahman A. Aljumah, Ibrahim H. Altraif, Tarik Asselah, Ziv Ben-Ari, Thomas Berg, Mia J. Biondi, Sarah Blach, Wornei S.M. Braga, Carlos E. Brandão-Mello, Maurizia R. Brunetto, Joaquin Cabezas, Hugo Cheinquer, Pei-Jer Chen, Myeong-Eun Cheon, Wan-Long Chuang, Carla S. Coffin, Nicola Coppola, Antonio Craxi, Javier Crespo, Victor De Ledinghen, Ann-Sofi Duberg, Ohad Etzion, Maria Lucia G. Ferraz, Paulo R.A. Ferreira, Xavier Forns, Graham R. Foster, Giovanni B. Gaeta, Ivane Gamkrelidze, Javier García-Samaniego, Liliana S. Gheorghe, Pierre M. Gholam, Robert G. Gish, Jeffrey Glenn, Julian Hercun, Yao-Chun Hsu, Ching-Chih Hu, Jee-Fu Huang, Naveed Janjua, Jidong Jia, Martin Kåberg, Kelly D.E. Kaita, Habiba Kamal, Jia-Horng Kao, Loreta A. Kondili, Martin Lagging, Pablo Lázaro, Jeffrey V. Lazarus, Mei-Hsuan Lee, Young-Suk Lim, Paul J. Marotta, Maria-Cristina Navas, Marcelo C.M. Naveira, Mauricio Orrego, Carla Osiowy, Calvin Q. Pan, Mário G. Pessoa, Giovanni Raimondo, Alnoor Ramji, Devin M. Razavi-Shearer, Kathryn Razavi-Shearer, Cielo Y. Ríos-Hincapié, Manuel Rodríguez, William M.C. Rosenberg, Dominique M. Roulot, Stephen D. Ryder, Rifaat Safadi, Faisal M. Sanai, Teresa A. Santantonio, Christoph Sarrazin, Daniel Shouval, Frank Tacke, Tammo L. Tergast, Juan Miguel Villalobos-Salcedo, Alexis S. Voeller, Hwai-I Yang, Ming-Lung Yu, Eli Zuckerman
Publikováno v:
Journal of Hepatology.